HHS Introduces New Resources for Drug Abuse Treatment

The Department of Health and Human Services has unveiled initiatives aimed at making drug abuse treatment more accessible and affordable for families who might face entering the foster care system.

The Administration for Children and Families at HHS will announce that three FDA-approved medications for Opioid Use Disorder are now eligible under Title IV-E, a federal funding program designed to assist families involved with child welfare.

According to the agency, enhancing access to these medications will enable parents to seek treatment for opioid addiction, thereby helping families to remain intact and minimizing the trauma children endure when separated from their parents.

“Denying parents affordable and effective treatment options for opioid addiction only fractures families,” said Health and Human Services Secretary Robert F. Kennedy, Jr., in a statement shared with The Daily Signal.

“Utilizing Title IV-E funding for these life-saving medications is essential for keeping families together and steering our system towards recovery and prevention.”

As a result, states and tribes can receive a 50% federal match to offer buprenorphine, methadone, and naltrexone to parents whose children are on the brink of entering foster care but can stay home with access to these medications.

Substance use disorders among parents significantly contribute to foster care placements. Currently, over 400,000 children are in foster care, many not due to abuse, but because a parent is grappling with addiction.

This initiative allows states to incorporate these medications into their Title IV-E Prevention Program and seek federal reimbursement once approved.

This expansion aligns with President Trump’s executive order from January 29, “Addressing Addiction Through the Great American Recovery Initiative.”

Additionally, it fits into ACF’s “A Home for Every Child” initiative, which strives for a greater than 1:1 foster home-to-child ratio across all states.

Preventing family separations is crucial to achieving this goal, according to ACF.

“At the Administration for Children and Families, we are removing barriers that have kept effective opioid use disorder treatments out of reach for many families,” remarked Assistant Secretary for Family Support Alex J. Adams.

“By fast-tracking these proven treatments, we are investing in effective prevention and providing states with powerful new tools to better support families.”